Positions

Selected Publications

Academic Article

Year Title Altmetric
2020 Single-dose intranasal administration of AdCOVID elicits systemic and mucosal immunity against SARS-CoV-2 in mice. 2020
2020 Erratum: Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus (Immunity (2018) 49(4) (725–739.e6), (S1074761318303789), (10.1016/j.immuni.2018.08.015))Immunity.  52:203. 2020
2019 Ifnγ induces epigenetic programming of human t-bethi b cells and promotes tlr7/8 and il-21 induced differentiationeLife.  8. 2019
2018 CD38 promotes pristane-induced chronic inflammation and increases susceptibility to experimental lupus by an apoptosis-driven and TRPM2-dependent mechanismScientific Reports.  8. 2018
2018 Human leukocyte antigen class I and II knockout human induced pluripotent stem cell–derived cells: Universal donor for cell therapy 2018
2018 Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus ErythematosusImmunity.  49:725-739.e6. 2018
2013 Increased CD38 expression in T cells and circulating anti-CD38 IgG autoantibodies differentially correlate with distinct cytokine profiles and disease activity in systemic lupus erythematosus patientsCytokine.  62:232-243. 2013
2013 Increased gene expression of Toll-like receptor 4 on peripheral blood mononuclear cells in patients with psoriasis.Journal of the European Academy of Dermatology and Venereology.  27:242-250. 2013
2012 Altered AKT1 and MAPK1 gene expression on peripheral blood mononuclear cells and correlation with T-helper-transcription factors in Systemic Lupus Erythematosus patientsMediators of Inflammation.  2012. 2012
2012 Increased expression and phosphorylation of the two S100A9 isoforms in mononuclear cells from patients with systemic lupus erythematosus: A proteomic signature for circulating low-density granulocytes 2012
2010 Exosomes from human lymphoblastoid B cells express enzymatically active CD38 that is associated with signaling complexes containing CD81, Hsc-70 and LynExperimental Cell Research.  316:2692-2706. 2010

Education And Training

  • Doctor of Philosophy Level Degree in Immunology, University of Granada 2010
  • Master's Level Degree in Immunology, University of Granada 2008
  • Bachelor's Level Degree in Biochemistry, University of Granada 2004
  • Bachelor's Degree in Pharmacy, Pharmaceutical Sciences, and Administration, University of Granada 2000
  • Full Name

  • Esther Zumaquero Martinez